Table 2 Endoscopic findings, EUS features, treatment and prognosis of undiagnosed ET
From: EUS in the diagnosis of pathologically undiagnosed esophageal tuberculosis
CaseNo. | Esophagoscopy findings | EUS features | Diagnostic anti- tuberculosis therapy | Prognosis |
|---|---|---|---|---|
1 | Middle part of esophagus, protruding lesion in the mucosa 0.8 X 3.0 cm with a central ulcer 0.3 X 0.5 cm | Thickening, poorly defined esophageal wall structure, enlarged para esophageal lymph nodes with scattered calcifications | Isoniazid + rifampicin + pyrazinamide + ethambutol, 3 months | Recovered according to endoscopy |
2 | Middle part of esophagus, protruding lesion in the mucosa 1.5 X 2.0 cm with a central ulcer 0.2 X 0.3 cm | Thickening, poorly defined esophageal wall structure, linked to an enlarged para esophageal lymph node | Isoniazid + rifampicin + pyrazinamide + ethambutol, 3 months | Recovered according to endoscopy |
3 | Middle part of esophagus, protruding lesion in the mucosa 2.0 X 3.0 cm with a central ulcer 0.5 X 0.8 cm | Thickening, poorly defined esophageal wall structure, with an enlarged para esophageal lymph node | Isoniazid + rifampicin + pyrazinamide + ethambutol, 10 months | Recovered according to endoscopy |
4 | Middle part of esophagus, protruding lesion in the mucosa 2.5 X 3.0 cm with central erosion 0.3 X 0.4 cm | Thickening, poorly defined esophageal wall structure, esophageal heterogeneously hypoechoic lesion with scattered calcifications, and the hypoechoic lesion was linked to an enlarged para-esophageal lymph node | Isoniazid + rifampicin + pyrazinamide + ethambutol, 5 months | Recovered according to endoscopy |
5 | Lower part of esophagus, protruding lesion in the mucosa 1.0 X 1.5 cm with central erosion, 0.2 X 0.2 cm | Thickening, poorly defined esophageal wall structure, with heterogeneously hypoechoic esophageal lesion, and interrupted partial esophageal adventitia | Isoniazid + rifampicin + pyrazinamide + ethambutol, 4 months | Improved according to endoscopy |
6 | Middle part of esophagus, submucosal bulge 0.8 X 1.0 cm with smooth surface | Thickening, poorly defined esophageal wall structure linked to an enlarged para-esophageal lymph node, with scattered calcifications | Isoniazid + rifampicin + pyrazinamide + ethambutol, 5 months | Recovered according to endoscopy |
7 | Upper part of esophagus, submucosal bulge 0.5 X 0.7 cm, and diverticulum | Thickening, poorly defined esophageal wall structure, with enlarged para-esophageal lymph nodes | Isoniazid + rifampicin + pyrazinamide + ethambutol, 9 months | Improved according to endoscopy |
8 | Middle part of esophagus, irregular ulcer 0.3 X 0.5 cm, with fistula | Thickening, poorly defined esophageal wall structure linked to an enlarged para-esophageal lymph node with scattered calcifications | Isoniazid + rifampicin + pyrazinamide + ethambutol, 6 months | Recovered according to endoscopy |
9 | Middle part of esophagus, multiple ulcers 0.3 X 0.5 cm – 0.5 X 0.6 cm | Thickening, poorly defined esophageal wall structure, with an enlarged para-esophageal lymph node | Isoniazid + rifampicin + pyrazinamide + ethambutol, 4 months | Recovered according to endoscopy |